BeStock  
Stocks › Biotechnology › ADRX

Adarx Pharmaceuticals ADRX

US equityMarket cap rank #2910Biotechnology
$12.79 −$1.37 (-9.68%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.79 0.00%
Open$14.03
Prev close$14.16
Day range$12.63 – $14.87
Volume708.8K
Market cap$1.42B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-15.5x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average -18.4x

Price / book2.7x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average -6.0x

#3616 of 5330 stocks by PB (1 = cheapest)

Price / sales257.7x
CheapRich

Below its usual level · 25th percentile, 5-year average 265.3x

#5028 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-26x-17x-7x2xSep '26Oct '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.28
Price vs. fair value-16.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.75 – -6.01 98% (pricier than usual) #3616 of 5330 (1 = cheapest)
PE -15.52 -9.05 -18.37 85% (pricier than usual) –
PS 257.70 513.93 265.31 25% (cheaper than usual) #5028 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ADRX.

Sign in to join the discussion.

Scroll to Top